Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway.

Zhou, Xueming; Liu, Chenyue; Liu, Yueyun; Ma, Qingyu; Zhao, Xin; Jiang, Youming; Li, Xiaojuan; Chen, Jia-Xu

Zhou, Xueming; Liu, Chenyue; Liu, Yueyun; Ma, Qingyu; Zhao, Xin; Jiang, Youming; Li, Xiaojuan; Chen, Jia-Xu.

Afiliação

Zhou X; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Liu C; School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Haerbin, China.
Liu Y; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Ma Q; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhao X; Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Jiang Y; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Li X; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Chen JX; Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Front Pharmacol ; 13: 1042762, 2022.

Article em En | MEDLINE | ID: mdl-36588727

Palavras-chave

NR2B; PI3K/Akt pathway; depression; glutamate; hippocampal CA1 region; xiaoyaosan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China